FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103123039> ?p ?o ?g. }

• W2103123039 endingPage "473" @default.
• W2103123039 startingPage "472" @default.
• W2103123039 abstract "While pioneers in the field such as Geoffrey Keynes and François Baclesse had reported techniques for breast conservation decades earlier, it was really in the 1980s that this form of treatment gained international recognition as a safe alternative to mastectomy. Several randomised trials played an influential part in this change of climate, including those conducted by major collaborative organisations, such as the European Organisation for Research and Treatment of Cancer (EORTC) in Europe [ 1 van Dongen J.A. Voogd A.C. Fentiman I.S. et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy European Organization for Research and Treatment of Cancer 10801 trial. J. Natl. Cancer Inst. 2000; 82: 1143-1150 Crossref Scopus (1046) Google Scholar ] and the National Cancer Institute (NCI) in North America [ 2 Lichter A.S. Lippman M.E. Danforth Jr., D.N. et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast a randomized trial of the National Cancer Institute. J. Clin. Oncol. 1992; 10: 976-983 Crossref PubMed Scopus (303) Google Scholar ]. Today, breast conservation is recognised as an acceptable option for most women presenting with early breast cancer and is certainly the preferred approach for a very substantial number of them. Recurrence rates within the breast of less than 1% per annum over the first 10 years are nowadays regarded as the expected standard for most groups of patients [ 3 Kurtz J.M. Recurrence in the conserved breast why all this fuss about risk factors?. Eur. J. Cancer. 1999; 35: 1752-1754 Abstract Full Text PDF PubMed Scopus (9) Google Scholar ] (even if the figure is to some extent an arbitrary one). It was not always thus: even many of the leaders in the field reporting results in the 1980s quoted local recurrence rates that were much higher [ 4 Bataini J.P. Picco C. Martin M. Calle R. Relation between time-dose and local control of operable breast cancer treated by tumorectomy and radiotherapy or radiotherapy alone. Cancer. 1978; 42: 20659-20665 Crossref Scopus (51) Google Scholar , 5 Harris J.R. Hellman S. Primary radiation therapy for early breast cancer. Cancer. 1983; 52: 2547-2552 Crossref Scopus (22) Google Scholar , 6 Stotter A.T. McNeese M.D. Ames F.C. Oswald M.J. Ellerbroek N.A. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer. 1989; 64: 2217-2225 Crossref PubMed Scopus (181) Google Scholar ], as did the two randomised trials (EORTC and NCI) referred to above. By contrast, in a more recent EORTC trial, the 5-year breast recurrence rate in a group of nearly 5500 patients treated in many centres was only 7.3 and 4.3% in groups given, respectively, 50 Gy radiation to the whole breast, and the same plus a tumour-bed ‘boost’ of 16 Gy [ 7 Bartelink H. Horiot J.-C. Poortmans P. et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N. Engl. J. Med. 2001; 345: 1378-1387 Crossref PubMed Scopus (837) Google Scholar ]." @default.
• W2103123039 created "2016-06-24" @default.
• W2103123039 creator A5047699437 @default.
• W2103123039 creator A5067846464 @default.
• W2103123039 date "2004-03-01" @default.
• W2103123039 modified "2023-10-18" @default.
• W2103123039 title "Is local control necessarily an indicator of quality?" @default.
• W2103123039 cites W1888411879 @default.
• W2103123039 cites W2009662925 @default.
• W2103123039 cites W2023874248 @default.
• W2103123039 cites W2037207338 @default.
• W2103123039 cites W2045945802 @default.
• W2103123039 cites W2066920146 @default.
• W2103123039 cites W2067924402 @default.
• W2103123039 cites W2088489947 @default.
• W2103123039 cites W2095349827 @default.
• W2103123039 cites W2101603546 @default.
• W2103123039 cites W2129180070 @default.
• W2103123039 cites W2172480593 @default.
• W2103123039 cites W2254643376 @default.
• W2103123039 cites W2460278724 @default.
• W2103123039 doi "https://doi.org/10.1016/j.ejca.2003.11.013" @default.
• W2103123039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14962710" @default.
• W2103123039 hasPublicationYear "2004" @default.
• W2103123039 type Work @default.
• W2103123039 sameAs 2103123039 @default.
• W2103123039 citedByCount "1" @default.
• W2103123039 countsByYear W21031230392016 @default.
• W2103123039 crossrefType "journal-article" @default.
• W2103123039 hasAuthorship W2103123039A5047699437 @default.
• W2103123039 hasAuthorship W2103123039A5067846464 @default.
• W2103123039 hasConcept C121608353 @default.
• W2103123039 hasConcept C126322002 @default.
• W2103123039 hasConcept C143998085 @default.
• W2103123039 hasConcept C168563851 @default.
• W2103123039 hasConcept C17744445 @default.
• W2103123039 hasConcept C199539241 @default.
• W2103123039 hasConcept C2777757722 @default.
• W2103123039 hasConcept C2779473830 @default.
• W2103123039 hasConcept C2781467025 @default.
• W2103123039 hasConcept C512399662 @default.
• W2103123039 hasConcept C530470458 @default.
• W2103123039 hasConcept C61434518 @default.
• W2103123039 hasConcept C71924100 @default.
• W2103123039 hasConcept C83867959 @default.
• W2103123039 hasConceptScore W2103123039C121608353 @default.
• W2103123039 hasConceptScore W2103123039C126322002 @default.
• W2103123039 hasConceptScore W2103123039C143998085 @default.
• W2103123039 hasConceptScore W2103123039C168563851 @default.
• W2103123039 hasConceptScore W2103123039C17744445 @default.
• W2103123039 hasConceptScore W2103123039C199539241 @default.
• W2103123039 hasConceptScore W2103123039C2777757722 @default.
• W2103123039 hasConceptScore W2103123039C2779473830 @default.
• W2103123039 hasConceptScore W2103123039C2781467025 @default.
• W2103123039 hasConceptScore W2103123039C512399662 @default.
• W2103123039 hasConceptScore W2103123039C530470458 @default.
• W2103123039 hasConceptScore W2103123039C61434518 @default.
• W2103123039 hasConceptScore W2103123039C71924100 @default.
• W2103123039 hasConceptScore W2103123039C83867959 @default.
• W2103123039 hasIssue "4" @default.
• W2103123039 hasLocation W21031230391 @default.
• W2103123039 hasLocation W21031230392 @default.
• W2103123039 hasOpenAccess W2103123039 @default.
• W2103123039 hasPrimaryLocation W21031230391 @default.
• W2103123039 hasRelatedWork W1579354567 @default.
• W2103123039 hasRelatedWork W1798582849 @default.
• W2103123039 hasRelatedWork W1987327643 @default.
• W2103123039 hasRelatedWork W2043478434 @default.
• W2103123039 hasRelatedWork W2074004671 @default.
• W2103123039 hasRelatedWork W2186537129 @default.
• W2103123039 hasRelatedWork W2375503453 @default.
• W2103123039 hasRelatedWork W2921362244 @default.
• W2103123039 hasRelatedWork W3199471150 @default.
• W2103123039 hasRelatedWork W4313643902 @default.
• W2103123039 hasVolume "40" @default.
• W2103123039 isParatext "false" @default.
• W2103123039 isRetracted "false" @default.
• W2103123039 magId "2103123039" @default.
• W2103123039 workType "article" @default.